La Roche-Posay Effaclar Duo+M, acne treatment gel-cream

La Roche-Posay Effaclar Duo+M Acne Treatment, 1.4 oz - 0.5% Salicylic Acid And 5.5% Benzoyl Peroxide

Published on 09/08/2026 at 08:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

La Roche-Posay Effaclar Duo+M Multi-Target Acne Treatment, 1.4 oz, combines 0.5% salicylic acid with 5.5% benzoyl peroxide for acne-prone, oily skin. For adults and teens with moderate breakouts, the dual-action formula and mid-range pricing matter most.

Schwarzweiss-Reportagebild mit Gesichtscreme in dokumentarischer Arbeitsumgebung
Schwarzweiss-Reportage mit Gesichtscreme zum Thema La Roche-Posay EFFACLAR Duo+, hoher Kontrast, sachlich dargestellt, Illustration mit AI erstellt.

La Roche-Posay Effaclar Duo+M Multi-Target Acne Treatment, 1.4 oz, targets acne-prone, oily skin with a combination of 0.5% salicylic acid and 5.5% benzoyl peroxide in a daily gel-cream texture designed for the face, chest and back. The 1.4 oz tube is positioned as a multi-target treatment for moderate breakouts.

Formula, Active Ingredients And Texture

Effaclar Duo+M uses 0.5% salicylic acid as an exfoliating active that penetrates pores to help clear existing acne blemishes and reduce the formation of new imperfections, while 5.5% benzoyl peroxide acts as the primary acne medication in the formula. The ingredient list highlights benzoyl peroxide 5.5% alongside water, glycerin, silica and carbomer in a gel-cream base.

The product is described as a fresh gel-cream texture that provides 24 hours of hydration and a long-lasting matte effect, absorbing quickly for a non-sticky, non-greasy finish suitable for daily use on acne-prone areas. The formula is also described as supporting sebum control and soothing the skin while helping protect against post-acne marks.

Indication, Use And Safety Profile

Effaclar Duo+M is designed for acne-prone and oily skin and is suitable for sensitive skin, with dermatologist-tested and non-comedogenic claims that make it appropriate for adults and teenagers with recurrent blemishes. The product information notes use on the face, chest and back as common application areas.

Usage directions focus on covering the entire affected area with a thin layer one to three times daily after thoroughly cleansing the skin, emphasizing that application frequency should be adjusted based on skin tolerance and dryness. As with other benzoyl peroxide treatments, the product literature warns about potential irritation and the need to manage dryness, but specific side effects follow standard benzoyl peroxide labeling.

Direct from the Manufacturer

Effaclar Duo+M Multi-Target Acne Treatment Overview

La Roche-Posay details the Effaclar Duo+M formula, indications and usage on its own site, including active ingredients and recommended routine steps.

Pricing, Size And Value Positioning

A US listing for Effaclar Duo+M Multi-Target Acne Treatment shows the 1.4 oz tube at a price of $24.14, placing it in a mid-range bracket for over-the-counter, derm-branded acne treatments. This price point reflects a premium over mass-market drugstore gels but remains below many luxury acne care serums as of 09/08/2026.

Earlier Effaclar Duo benzoyl peroxide formulations with similar 1.35 fl oz size have been documented at prices around $20.99 to $34.99 depending on retailer and specific packaging, indicating that Effaclar Duo+M continues La Roche-Posay's strategy of mid-range pricing with active-focused formulas. The combination of clinical actives and accessible pricing is typical for the Effaclar line.

Comparison With Earlier Effaclar Duo Formulas

Effaclar Duo+M builds on the earlier Effaclar Duo Dual Action Acne Treatment, which paired 5.5% micronized benzoyl peroxide with La Roche-Posay's Lipo-Hydroxy Acid in a 1.35 fl oz format, by adding 0.5% salicylic acid and microbiome-focused elements such as Phylobioma and Procerad ceramide. The shift toward salicylic acid and post-acne mark care aims to broaden the treatment targets beyond inflammatory lesions.

La Roche-Posay notes that the earlier Effaclar Duo spot treatment has been discontinued in favor of newer Effaclar salicylic acne formulas, and Duo+M follows that evolution by combining benzoyl peroxide with standardized salicylic acid levels and support ingredients for sebum control and dark mark reduction. For users familiar with the previous formula, Duo+M offers similar benzoyl peroxide strength with added exfoliation and complexion-evening elements.

Placement In Acne Care And Who It Suits

Within acne care, Effaclar Duo+M Multi-Target Acne Treatment sits between simple single-active drugstore gels and prescription-strength regimens, offering a combination of benzoyl peroxide and salicylic acid plus support ingredients tailored to oily, acne-prone and sensitive skin that benefits from derm-tested formulations. The gel-cream format, matte finish and face-chest-back usability make it a practical choice for those managing breakouts across multiple areas.

For US shoppers comparing Effaclar Duo+M with alternatives, the 0.5% salicylic acid and 5.5% benzoyl peroxide combination, 1.4 oz size and mid-range price around $24 suggest it will appeal most to adults and teens who want a derm-branded, multi-action treatment without stepping into prescription territory, while they still need to balance potential dryness against the benefits in clearing blemishes and post-acne marks. In that segment, clinical actives and texture-focused benefits are central to its positioning.

Effaclar Duo+M At A Glance

  • Product: La Roche-Posay Effaclar Duo+M Multi-Target Acne Treatment, 1.4 oz
  • Manufacturer: La Roche-Posay (Beiersdorf Inc., Stamford, CT)
  • Category: Over-the-counter acne treatment gel-cream
  • Active ingredients: Benzoyl peroxide 5.5% (acne medication), salicylic acid 0.5%
  • Texture and finish: Fresh gel-cream, 24-hour hydration, long-lasting matte effect
  • Price: $24.14 for 1.4 oz (as of 09/08/2026)
  • Target audience: Adults and teenagers with oily, acne-prone and sensitive skin seeking multi-target, derm-branded treatment

Find Effaclar Duo+M In Social Media

Disclaimer...

en | wirtschaft | 70067231 |